Cognitive-behavioral stress management reduces serum cortisol by enhancing benefit finding among women being treated for early stage breast cancer

Psychosomatic Medicine

Volumn 62, Issue 3, 2000, Pages 304-308

  Cruess, Dean G ^a   Antoni, Michael H ^a,b   McGregor, Bonnie A ^a   Kilbourn, Kristin M ^a   Boyers, Amy E ^a   Alferi, Susan M ^a   Carver, Charles S ^a   Kumar, Mahendra ^a,b  

^a Department of Biology   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Benefit finding; Breast cancer; Cognitive behavioral stress management; Cortisol

Indexed keywords

HYDROCORTISONE;

ADULT; ARTICLE; BEHAVIOR THERAPY; BREAST CANCER; CANCER STAGING; CLINICAL ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; DISTRESS SYNDROME; EXPERIENCE; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; PRIORITY JOURNAL; STRESS;

EID: 0034116565     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006842-200005000-00002     Document Type: Article

References (23)

1. Touitou Y, Bogdan A, Levi F, Benavides M, Auzeby A. Disruption of the circadian patterns of serum cortisol in breast and ovarian cancer patients: relationships with tumour marker antigens. Br J Cancer 1996;74:1248-52.
2. van der Pompe G, Antoni MH, Heijnen CJ. Elevated basal cortisol levels and attenuated ACTH and cortisol responses to a behavioral challenge in women with metastatic breast cancer. Psychoneuroendocrinology 1996;21:361-74.
3. Stanton AL, Snider PR. Coping with a breast cancer diagnosis: a prospective study. Health Psychol 1993;12:16-23.
4. Carver CS, Pozo-Kaderman C, Price AA, Noriega V, Harris SD, Derhagopian RP, Robinson DS, Moffatt FL. Concern about aspects of body image and adjustment to early stage breast cancer. Psychosom Med 1998;60:168-74.
5. Andersen BL. Psychological interventions for cancer patients to enhance the quality of life. J Consult Clin Psychol 1992;60: 552-68.
6. Trijsburg RW, van Knippenberg FCE, Rijpma SE. Effects of psychological treatment on cancer patients: a critical review. Psychosom Med 1992;54:489-517.
7. van der Pompe G, Duivenvoorden HJ, Antoni MH, Visser A, Heijnen CJ. Effectiveness of a short-term group psychotherapy program on endocrine and immune function in breast cancer patients: an exploratory study. J Psychosom Res 1997;42: 453-66.
8. Schedlowski M, Jung C, Schimanski G, Tewes U, Schmoll HJ. Effects of behavioral intervention on plasma cortisol and lymphocytes in breast cancer patients: an exploratory study. Psychooncology 1994;3:181-7.
9. Fromm K, Andrykowski MA, Hunt J. Positive and negative psychosocial sequelae of bone marrow transplantation: implications for quality of life assessment. J Behav Med 1996;19: 221-40.
10. Tedeschi RG, Calhoun LG. Trauma and transformation: growing in the aftermath of suffering. Thousand Oaks (CA): Sage; 1995.
11. Antoní MH, Carver C, Boyers A, McGregor B, Arena P, Lehman J, Harris S, Price A, Alferi S, Culver J, Cruess DG. Cognitive-behavioral stress management intervention enhances optimism and the sense of positive contribution among women under treatment for early stage breast cancer [abstract]. Psychosom Med 1999;61:94.
12. McNair D, Lorr M, Droppleman L. Manual for the Profile of Mood States. San Diego (CA): Educational and Industrial Testing Service; 1981.
13. Carver CS, Pozo C, Harris SD, Noriega V, Scheier MF, Robinson DS, Ketcham AS, Moffat FL, Clark KC. How coping mediates the effect of optimism on distress: a study of women with early stage breast cancer. J Pers Social Psychol 1993;65:375-90.
14. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986;51:1173-82.
15. Berk L, Bittmen B, Covington T, Bickford K, Tom S, Westengard J. A video presentation of music, nature's imagery, and positive affirmations as a combined eustress paradigm modulates neuroendocrine hormones [abstract]. Ann Behav Med 1997;19:201.
16. Buchanan T, al'Absi M, Lovallo W. Cortisol fluctuates with increases and decreases in negative affect. Psychoneuroendocrinology 1999;24:227-41.
17. Smyth J, Ockenfels M, Porter L, Kirschbaum C, Hellhammer D, Stone AA. Stressors and mood measured on a momentary basis are associated with salivary cortisol secretion. Psychoneuroendocrinology 1998;23:353-70.
18. McEwen B. Protective and damaging effects of stress mediators. N Engl J Med 1998;338:171-9.
19. Antoni MH, Wagner S, Cruess DG, Kumar M, Ironson G. Schneiderman N. Cognitive behavioral stress management effects on distress and adrenal hormones in HIV-infected gay men [abstract]. Psychosom Med 1999;61:127.
20. Antoni MH, Baggett L, Ironson G, LaPerriere A, August S, Klimas N, Schneiderman N, Fletcher MA. Cognitive-behavioral stress management intervention buffers distress responses and immunologic changes following notification of HIV-1 seropositivity. J Consult Clin Psychol 1991;59:906-15.
21. Lutgendorf SK, Antoni MH, Ironson G, Klimas N, Kumar M, Starr K, McCabe P, Cleven K, Fletcher MA, Schneiderman N. Cognitive-behavioral stress management decreases dysphoric mood and herpes simplex virus-type 2 antibody titers in symptomatic HIV-seronegative gay men. J Consult Clin Psychol 1997; 65:31-43.
22. Stone AA, Neale JM, Cox DS, Napoli A, Valdimarsdottir H, Kennedy-Moore E. Daily events are associated with a secretory immune response to an oral antigen in men. Health Psychol 1994;13:440-6.
23. Bower J, Kemeny M, Taylor S, Fahey J. Cognitive processing, discovery of meaning, CD4 decline, and AIDS-related mortality among bereaved HIV-seropositive men. J Consult Clin Psychol 1998;66:979-86.